Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas

BMC Medical Genomics

Volumn 7, Issue 1, 2014, Pages

  Ouyang, Limei ^a   Lee, Jeeyun ^b   Park, Cheol Keun ^b   Mao, Mao ^c   Shi, Yujian ^a   Gong, Zhuolin ^a   Zheng, Hancheng ^a   Li, Yingrui ^a   Zhao, Yonggang ^a   Wang, Guangbiao ^a   Fu, Huiling ^a   Kim, Jhingook ^b   Lim, Ho Yeong ^b  

^a BGI SHENZHEN   (China)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c PFIZER INC   (United States)

Author keywords

Cancer; Hepatocellular carcinomas (HCC); Lung metastasis; Next generation sequencing (NGS); Somatic

Indexed keywords

ADENINE; BRCA1 PROTEIN; CBL PROTEIN; CYTOSINE; GUANINE; MYC PROTEIN; SORAFENIB; SUNITINIB; THYMINE; ZINC FINGER PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COPY NUMBER VARIATION; CPG ISLAND; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER LOBECTOMY; LUNG LOBECTOMY; LUNG METASTASIS; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TREATMENT FAILURE; TUMOR VOLUME;

ADULT; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; FATAL OUTCOME; GENE FREQUENCY; GENOME, HUMAN; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; RNA SPLICE SITES; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION;

EID: 84892166586     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-7-2     Document Type: Article

References (37)

1. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. El-Serag HBRK, Gastroenterology 2007 132 2557 2576 10.1053/j.gastro.2007.04.061 17570226
2. Global patterns of cancer incidence and mortality rates and trends. Jemal A, Center MM, DeSantis C, Ward EM, Cancer Epidemiol Biomarkers Prev 2010 19 1893 1907 10.1158/1055-9965.EPI-10-0437 20647400
3. Global cancer transitions according to the human development index (2008-2030): a population-based study. Bray F, Jemal A, Grey N, Ferlay J, Forman D, Lancet Oncol 2012 13 790 801 10.1016/S1470-2045(12)70211-5 22658655
4. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
5. Hepatocellular carcinoma: current management and perspectives for the future. Rahbari NNMA, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J, Ann Surg 2011 253 453 469 10.1097/SLA.0b013e31820d944f 21263310
6. Clinical features of hepatocellular carcinoma with extrahepatic metastases. Natsuizaka MOT, Akaike T, Kuwata Y, Yamazaki K, Sato T, Karino Y, Toyota J, Suga T, Asaka M, J Gastroenterol Hepatol 2005 20 1781 1787 10.1111/j.1440-1746.2005.03919.x 16246200
7. Extrahepatic metastases of hepatocellular carcinoma. Katyal SOJ 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL, Radiology 2000 216 698 703 10.1148/radiology.216.3.r00se24698 10966697
8. Whole genome sequencing of matched primary and metastatic acral melanomas. Turajlic SFS, Lambros MB, Mitsopoulos C, Kozarewa I, Geyer FC, Mackay A, Hakas J, Zvelebil M, Lord CJ, Ashworth A, Thomas M, Stamp G, Larkin J, Reis-Filho JS, Marais R, Genome Res 2012 22 196 207 10.1101/gr.125591.111 22183965
9. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Campbell PJYS, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA, Morsberger LA, Latimer C, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal SA, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Griffin CA, Burton J, Swerdlow H, Quail MA, Stratton MR, Iacobuzio-Donahue C, Futreal PA, Nature 2010 467 1109 1113 10.1038/nature09460 20981101
10. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Yachida SJS, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA, Nature 2010 467 1114 1117 10.1038/nature09515 20981102
11. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Sung WKZH, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, Mulawadi FH, Wong KF, Liu AM, Poon RT, Fan ST, Chan KL, Gong Z, Hu Y, Lin Z, Wang G, Zhang Q, Barber TD, Chou WC, Aggarwal A, Hao K, Zhou W, Zhang C, Hardwick J, Buser C, Xu J, Kan Z, Dai H, Mao M, Reinhard C, Wang J, Luk JM, Nat Genet 2012 44 765 769 10.1038/ng.2295 22634754
12. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas. Li SMMS, Mao M, Cancer Lett 2013 340 2 247 53 10.1016/j.canlet.2012. 09.027 23063663
13. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Ding LLT, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, Shannon WD, et al. Nature 2012 481 506 510 10.1038/nature10738 22237025
14. A census of human cancer genes. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR, Nat Rev Cancer 2004 4 177 183 10.1038/nrc1299 14993899
15. Endogenous human microRNAs that suppress breast cancer metastasis. Tavazoie SFAC, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J, Nature 2008 451 147 152 10.1038/nature06487 18185580
16. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Wang JMC, Easton J, Roberts S, Heatley SL, Ma J, Rusch MC, Chen K, Harris CC, Ding L, Holmfeldt L, Payne-Turner D, Fan X, Wei L, Zhao D, Obenauer JC, Naeve C, Mardis ER, Wilson RK, Downing JR, Zhang J, Nat Methods 2011 8 652 654 10.1038/nmeth.1628 21666668
17. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. Hoshida YVA, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR, N Engl J Med 2008 359 1995 2004 10.1056/NEJMoa0804525 18923165
18. Differential Differentiation- and Survival and Invasion-related T-/H-cadherin (CDH13) Computational Downstream Network from No-Tumor Hepatitis/Cirrhosis (HBV or HCV infection) to Human Hepatocellular Carcinoma (HCC) Malignant Transformation. Wang L, Wu H, Jiang M, Huang J, Lin H, et al. J Mol Biomark Diagn 2012 2 127
19. Identifying cancer driver genes in tumor genome sequencing studies. Youn ASR, Bioinformatics 2011 27 175 181 10.1093/bioinformatics/btq630 21169372
20. Metastasis: from dissemination to organ-specific colonization. Nguyen DX, Bos PD, Massague J, Nat Rev Cancer 2009 9 274 284 10.1038/nrc2622 19308067
21. The global health burden of infection-associated cancers in the year 2002. Parkin DM, Int J Cancer 2006 118 3030 3044 10.1002/ijc.21731 16404738
22. Trends in liver cancer researched by the Liver Cancer Study Group of Japan. Kakumu S, Hepatol Res 2002 24 21 S27
23. Prognostic analysis of pulmonary metastases from hepatocellular carcinoma. Zhang SMZZ, Tang ZY, Sun J, Cheng JM, Liu R, Wang P, Zhang BH, Hepatol Int 2008 2 237 243 10.1007/s12072-008-9052-7 19669310
24. Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Yoon YSKH, Kim J, Choi YS, Shim YM, Paik SW, Kim K, Ann Surg Oncol 2010 17 2795 2801 10.1245/s10434-010-1073-5 20517683
25. Structural classification of zinc fingers: survey and summary. Krishna SS, Majumdar I, Grishin NV, Nucleic Acids Res 2003 31 532 550 10.1093/nar/gkg161 12527760
26. Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Cradick TJ, Keck K, Bradshaw S, Jamieson AC, McCaffrey AP, Mol Ther 2010 18 947 954 10.1038/mt.2010.20 20160705
27. A pilot study comparing HPV-positive and HPV-negative head and neck squamous cell carcinomas by whole exome sequencing. Nichols AC, Chan-Seng-Yue M, Yoo J, Xu W, Dhaliwal S, Basmaji J, Szeto CC, Dowthwaite S, Todorovic B, Starmans MH, et al. ISRN Oncol 2012 2012 809370 23304554
28. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, Atabey N, Ozturk M, Mol Cancer 2009 8 90 10.1186/1476-4598-8-90 19849855
29. WNT5A-target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Ripka SKA, Buchholz M, Wagner M, Sipos B, Klöppel G, Downward J, Gress T, Michl P, Carcinogenesis 2007 28 1178 1187 10.1093/carcin/bgl255 17227781
30. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Hu MKM, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG, Gastroenterology 2007 133 1579 1591 10.1053/j.gastro.2007.08.036 17983805
31. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Yang WYH, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN, Chen C, Liu SQ, Wu MC, Wang HY, Cancer Res 2008 68 4287 4295 10.1158/0008-5472.CAN-07-6691 18519688
32. The opposing roles of Wnt-5a in cancer. McDonald SLSA, Br J Cancer 2009 101 209 214 10.1038/sj.bjc.6605174 19603030
33. Signaling pathways that control cell migration: models and analysis. Welf ES, Haugh JM, Wiley Interdiscip Rev Syst Biol Med 2011 3 231 240 10.1002/wsbm.110 21305705
34. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Beroukhim RGG, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, Perner S, Prensner J, Debiasi RM, Demichelis F, Hatton C, Rubin MA, Garraway LA, Nelson SF, Liau L, Mischel PS, Cloughesy TF, Meyerson M, Golub TA, Lander ES, Mellinghoff IK, Sellers WR, Proc Natl Acad Sci U S A 2007 104 20007 20012 10.1073/pnas.0710052104 18077431
35. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Subramanian ATP, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP, Source, Broad Institute of Massachusetts Institute of Technology and Harvard CS, Cambridge, MA 02141, USA, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517
36. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Mootha VKLC, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC, Nat Genet 2003 34 267 273 10.1038/ng1180 12808457
37. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Michaelson JJSY, Gujral M, Zheng H, Malhotra D, Jin X, Jian M, Liu G, Greer D, Bhandari A, Wu W, Corominas R, Peoples A, Koren A, Gore A, Kang S, Lin GN, Estabillo J, Gadomski T, Singh B, Zhang K, Akshoomoff N, Corsello C, McCarroll S, Iakoucheva LM, Li Y, Wang J, Sebat J, Cell 2012 151 1431 1442 10.1016/j.cell.2012.11.019 23260136